Search results
Results from the WOW.Com Content Network
The incremental cost-effectiveness ratio (ICER) is a statistic used in cost-effectiveness analysis to summarise the cost-effectiveness of a health care intervention. It is defined by the difference in cost between two possible interventions, divided by the difference in their effect.
ICER's affordability calculations adjust for drugs targeting prevalent diseases and/or those presenting a significant clinical benefit by setting the threshold at double the available funds divided by the expected number of new drugs (approved by FDA). [1] [2] Since 2016, ICER has valued one quality-adjusted life year as worth $150,000. [7]
All NIH Institutes and Centers are involved with OSC in the design, implementation, and evaluation of Common Fund programs. [15] commonfund.nih.gov: Office of Technology Transfer: OTT manages the wide range of NIH and FDA intramural inventions as mandated by the Federal Technology Transfer Act and related legislation.
Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE ...
The CSR organizes the peer review groups or study sections that evaluate the majority (76%) of the research grant applications sent to NIH. [1] It also receives all grant applications for NIH, as well as for some other components of the United States Department of Health and Human Services (DHHS). Since 1946, its mission has remained clear and ...
This section needs to be updated. The reason given is: Add information about HHS making public more information about clinical trials (see link). Please help update this article to reflect recent events or newly available information. (September 2016)
Bath & Body Works has struggled with consumers and investors as the pandemic beauty boom faded. Its shares are down nearly 14% year to date, compared to the S&P 500's 27% gain.
The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. [1] With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational , and clinical research, the NIH Intramural Research Program ...